SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,515.43 362.57
( 0.48%)

Global Indices

Nasdaq

53,682.77 599.82
(1.13%)

Dow Jones

7,765.55 77.95
(1.01%)

Hang Seng

65,002.68 788.20
(1.23%)

Nikkei 225

10,828.70 -2.82
(-0.03%)

Forex

USD-INR

94.73 -0.22
(-0.23%)

EUR-INR

109.71 -0.40
(-0.36%)

GBP-INR

127.83 -0.65
(-0.50%)

JPY-INR

0.59 0.00
(0.14%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Rubicon Research Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

544578

INE506V01022

81.7556682

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

RUBICON

124.76

29367.84

EPS(TTM)

Face Value()

Div & Yield %

14.22

0.08

Back

him teknoforge ltd

KSB consolidated net profit declines 18.75% in the June 2026 quarter

Aug 04,2026

Net profit of KSB declined 18.75% to Rs 57.20 crore in the quarter ended June 2026 as against Rs 70.40 crore during the previous quarter ended June 2025. Sales rose 3.60% to Rs 690.70 crore in the quarter ended June 2026 as against Rs 666.70 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	690.70	666.70	4
OPM %	11.81	13.71	-
PBDT	89.50	106.20	-16
PBT	74.70	92.20	-19
NP	57.20	70.40	-19

76,515.43 362.57 ( 0.48%)

53,682.77 599.82 (1.13%)

7,765.55 77.95 (1.01%)

65,002.68 788.20 (1.23%)

10,828.70 -2.82 (-0.03%)

94.73 -0.22 (-0.23%)

109.71 -0.40 (-0.36%)

127.83 -0.65 (-0.50%)

0.59 0.00 (0.14%)